title: Five-year experience with depot medroxy progesterone acetate injectable contraception.
abstract: BACKGROUND
  The objective of this article is to describe the characteristics and experiences of clients who used depot medroxy progesterone acetate for contraception.
  
  
  METHODS
  A retrospective review of family planning records of clients who used depo-provera between 1992 and 1996 at the family planning clinic of University of Nigerian Teaching Hospital, Enugu.
  
  
  RESULTS
  The mean age of clients was 32.7 +/- 5.2 years. Over 71% of clients had five or more children. Clients with no education (78.7%) or primary education (75.1%) were more likely to be grand-multiparous compared to women with at least secondary education (49.6%). Among clients with 1-4 living children, 81.3% used depo-provera for child spacing. Among those with 5-8 living children, 48.8% used it for child spacing. Menstrual abnormalities were the main complications but the commonest reason given for discontinuation was "husband's wish". The continuation rate at 36 months was 82.7%.
  
  
  CONCLUSIONS
  Depot medroxy progesterone acetate is an acceptable and effective method of contraception. The involvement of men in family planning programmes cannot be over-emphasised as they significantly influence the decision of women regarding contraceptive use.
authors.affiliation: Department of Obstetrics and Gynaecology, University of Nigeria Teaching Hospital, Enugu, Nigeria.
authors.forename: F O
authors.initials: FO
authors.lastname: Ezugwu
authors.forename: S E
authors.initials: SE
authors.lastname: Anya
mesh_terms: D000328:Adult; D003271:Contraceptive Agents, Female / Q000008:administration & dosage*; D004522:Educational Status; D005260:Female; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D017258:Medroxyprogesterone Acetate / Q000008:administration & dosage*; D008875:Middle Aged; D009549:Nigeria; D010298:Parity; D011247:Pregnancy; D012189:Retrospective Studies
chemical_list: D003271:Contraceptive Agents, Female; D017258:Medroxyprogesterone Acetate